Tybourne Capital Management Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 7

Professionals

  • Investments
  • 38

  • Portfolio
  • 15

  • Exits
  • 16

Exits

Tybourne Capital Management General Information

Company Description

Founded in 2010, Tybourne Capital Management is a growth equity investment firm based in Hong Kong. The firm seeks to invest in consumer, financial, healthcare, technology, and media sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Formerly Known As
Aquila Equity Advisors Limited, Kesari Hong Kong Limited
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Corporate Office
  • Suites 818-822, 8/Floor, Bank of America Tower
  • 12 Harcourt Road
  • Hong Kong
  • Hong Kong
+852 3983

Tybourne Capital Management Investments (38)

Tybourne Capital Management’s most recent investment was a with Z-Alpha Therapeutics. The deal was made on 12-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Z-Alpha Therapeutics 12-Nov-2026 Drug Discovery Generating Revenue
Bumi Berkah Boga 24-Sep-2026 Beverages Profitable
Allotera Therapeutics 08-Jul-2026 Drug Discovery Clinical Trials - Phase 2
Talentio 19-Mar-2026 Business/Productivity Software Generating Revenue
Asuene 23-Oct-2025 Later Stage VC Other Energy Services Generating Revenue
You’re viewing 5 of 38 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tybourne Capital Management Exits (16)

Tybourne Capital Management has made a total of 16 exits. Its latest exit was from Zentalis Pharmaceuticals for on 17-Aug-2026. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Zentalis Pharmaceuticals 17-Aug-2026
Forte Biosciences 10-Apr-2026
Upsider 29-Jul-2025
OneSource Specialty Pharma 24-Jan-2025
Lunit 09-Nov-2023 Public Investment 2nd Offering
You’re viewing 5 of 16 exits. Get the full list »

Tybourne Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Tybourne Capital Management FAQs

  • What is Tybourne Capital Management?

    Founded in 2010, Tybourne Capital Management is a growth equity investment firm based in Hong Kong.

  • When was Tybourne Capital Management founded?

    Tybourne Capital Management was founded in 2010.

  • Where is Tybourne Capital Management headquartered?

    Tybourne Capital Management is headquartered in Hong Kong, Hong Kong.

  • What is Tybourne Capital Management's total asset value?

    Tybourne Capital Management has around in total assets under management.

  • How many investments has Tybourne Capital Management made?

    Tybourne Capital Management has made 38 investments.

  • What has Tybourne Capital Management invested in?

    Tybourne Capital Management has made numerous investments in companies like Z-Alpha Therapeutics, Bumi Berkah Boga, and Allotera Therapeutics within the Drug Discovery and Beverages industries.

  • What has Tybourne Capital Management invested in recently?

    Tybourne Capital Management's latest investment was on 12-Nov-2026 in Z-Alpha Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process